Gene · 3978
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Factors That Affect the Formation of Chromosomal Translocations in Cells. | Cancers (Basel) | 2022 | 36291894 | PubTator, text mining | PubMed |
| Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin. | J Transl Med | 2022 | 36273153 | PubTator, text mining | PubMed |
| Catalytically inactive DNA ligase IV promotes DNA repair in living cells. | Nucleic Acids Res | 2022 | 36263813 | PubTator, text mining | PubMed |
| Emetine blocks DNA replication via proteosynthesis inhibition not by targeting Okazaki fragments. | Life Sci Alliance | 2022 | 36260751 | PubTator, text mining | PubMed |
HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs. | Oncotarget | 2022 | 36243940 | PubTator, text mining | PubMed |
| The UHRF protein family in epigenetics, development, and carcinogenesis. | Proc Jpn Acad Ser B Phys Biol Sci | 2022 | 36216533 | PubTator, text mining | PubMed |
| DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities. | Exp Mol Med | 2022 | 36207426 | PubTator, text mining | PubMed |
| Identification of molecular subtypes of coronary artery disease based on ferroptosis- and necroptosis-related genes. | Front Genet | 2022 | 36204316 | PubTator, text mining | PubMed |
| Dynamic allostery in substrate binding by human thymidylate synthase. | Elife | 2022 | 36200982 | PubTator, text mining | PubMed |
| Single-cell RNA-seq uncovered hemocyte functional subtypes and their differentiational characteristics and connectivity with morphological subpopulations in Litopenaeus vannamei. | Front Immunol | 2022 | 36177045 | PubTator, text mining | PubMed |
| A New Complex Design of Fe (II) Isoleucine Dithiocarbamate as a Novel Anticancer and Antivirus against SARSCOV-2 (COVID-19). | Asian Pac J Cancer Prev | 2022 | 36172674 | PubTator, text mining | PubMed |
| Mesenchymal gene expression subtyping analysis for early-stage human papillomavirus-negative head and neck squamous cell carcinoma reveals prognostic and predictive applications. | Front Oncol | 2022 | 36147910 | PubTator, text mining | PubMed |
| Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways. | Molecules | 2022 | 36144625 | PubTator, text mining | PubMed |
| Knockout and Inhibition of Ape1: Roles of Ape1 in Base Excision DNA Repair and Modulation of Gene Expression. | Antioxidants (Basel) | 2022 | 36139891 | PubTator, text mining | PubMed |
| Lagging strand gap suppression connects BRCA-mediated fork protection to nucleosome assembly through PCNA-dependent CAF-1 recycling. | Nat Commun | 2022 | 36085347 | PubTator, text mining | PubMed |
| The Role of Protein Arginine Methyltransferases in DNA Damage Response. | Int J Mol Sci | 2022 | 36077176 | PubTator, text mining | PubMed |
| Conversion of hepatitis B virus relaxed circular to covalently closed circular DNA is supported in murine cells. | JHEP Rep | 2022 | 36035363 | PubTator, text mining | PubMed |
| Genome Protection by DNA Polymerase θ. | Annu Rev Genet | 2022 | 36028228 | PubTator, text mining | PubMed |
| Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation. | Viruses | 2022 | 36016386 | PubTator, text mining | PubMed |
| A Proteomic Approach to Study the Biological Role of Hepatitis C Virus Protein Core+1/ARFP. | Viruses | 2022 | 36016316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3978/papers?page=14